Advances in the Management of Brain Tumors in Infants

Authors: Massimi, Luca; Pettorini, Benedetta; Tamburrini, Gianpiero; Caldarelli, Massimo; Di Rocco, Concezio

Source: Current Cancer Therapy Reviews, Volume 7, Number 3, August 2011 , pp. 184-200(17)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $71.00 plus tax (Refund Policy)

Abstract:

The last two decades have been crucial for neurooncology due to the enormous progress in the base research and in the medical technology. Such a continuous development has significantly improved the knowledge on the genetics and molecular biology of brain tumors, thus allowing to better define their prognosis and to find new therapeutic targets. Furthermore, it has provided sophisticated diagnostic and therapeutic tools that have radically changed the behavior of neurosurgeons, neurooncologists, and radiotherapists with regards to these neoplasms.

Once considered rare and poorly treatable, infantile brain tumors (IBTs) are currently more and more diagnosed and benefit of the aforementioned progresses so that their prognosis has become quite similar to that of the older ages. The aim of the present paper is to review the factors that favored these advances and to analyze the main aspects concerning IBTs, namely:

Current information on epidemiology and etiology;

- Advances in the neuroimaging;

- Changes in the surgical attitude;

- Development of ad hoc chemotherapic and radiotherapic protocols;

- The role of pathology and molecular biology in the prognosis;

- Outcome;

- Future directions.

Keywords: Infantile brain tumor; intracranial neoplasm; neuroimaging; molecular biology

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157339411796234933

Publication date: 2011-08-01

More about this publication?
  • Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page